Our Team


Jason R. Phillips

CTO & Director of Business Development

Mr. Phillips is an engineer and polymer expert with over twenty-two years of experience in project management, product development and business development in the medical device, pharmaceutical and biotech industries.  He has held senior R&D engineering positions at Abbott Labs, Philips Healthcare, and Johnson & Johnson.  He also held the position of Product Development Manager for Lubrizol Lifesciences, where he oversaw cross-functional teams of marketing, manufacturing and new product development.  Mr. Phillips earned a B.S. in Mechanical Engineering from Henry Cogswell College, is a University of Massachusetts Lowell Graduate in Polymer Technology, a University of Washington Graduate in Program Management, and has executed numerous patents in the life sciences industry. 



William Ballard


Mr. Ballard graduated from Duke with a B.S. degree in accounting. He held senior executive positions in several of the world’s largest commercial real estate firms. Recently, he started the financial and accounting divisions for IndCor Properties, Inc.  and he is a managing partner at i3 Realty.



Beverly Wolgast, Ph.D.


Dr. Wolgast received her B.S. in Chemistry from Rensselaer Polytechnic Institute, her Ph.D. in Synthetic Organic Chemistry from Brandeis University and her post-doctoral Fellowship from Harvard University. With over 30 years of experience in pharmaceutical and biotechnology industries, she has worked at Arena, Celgene, Takeda, and Novartis, assuming leadership roles at each company.


Board Members

Kirk Avery

Chairman, Co-founder

Mr. Kirk graduated from Stanford with a B.S. degree in Economics. He has been investing in venture capital and real estate for over 30 years. His investments span energy, tech companies, consumer goods, private operating companies, VC funds, and biotechnology.

Ted DeFrank


Mr. DeFrank is CEO, President, and CFO of Active Motif. He led the acquisitions and subsequent integrations of LP Bio, GenPathway, and SwitchGear Genomics. He has also served as President and General Manager of Pierce Biotechnology, CEO of Assay Designs, and COO of Invitrogen.

Stephen Wasserman


Mr. Wasserman is a consultant and business advisor with extensive experience as a Senior Operating executive and CFO, driving global organizations to outperform expectations for revenue, profits, and growth. He has extensive experience working in the medical device, diagnostic systems, and biotechnology and pharmaceutical sectors.

James J. Woodcock


Mr. Woodcock has extensive business experience both domestically and internationally. Previous positions include former director at Xerox;  CEO Hy-Bon, CNG, Transrepublic Resources; former Chairman Teton Energy Corporation. He has been a Director and Investor at Diomics since 2010.

Get In Touch.

If you are interested in working together, send us an inquiry and we will get back to you as soon as we can.

Copyright ©2019 Diomics Corporation. All rights reserved.